Chuangxinmycin (CED0023800)

Record Information
Version1.0
Creation Date2026-03-31 20:58:35 UTC
Update Date2026-05-20 19:29:04 UTC
SynCED IDCED0023800
Secondary Accession Numbers
  • CHEM057928
Identification
Common NameChuangxinmycin
ClassSmall Molecule
Description
Chuangxinmycin is an organoheterocyclic compound with the formula C12H11N1O2S1 and an average molecular weight of 233.29 g/mol. Chuangxinmycin belongs to the indoles, a subclass of indoles and derivatives within the organic compounds. This substance is found in or released from healthcare, pharmaceuticals, and veterinary products, specifically antibiotics. Recorded exposure routes for the compound include inhalation and oral administration.
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC12H11N1O2S1
Average Molecular Mass233.290 g/mol
Monoisotopic Mass233.051 g/mol
CAS Registry Number63339-68-4
IUPAC NameNot Available
Traditional NameNot Available
SMILESC[C@@H]1[C@@H](SC2=CC=CC3=C2C1=CN3)C(O)=O
InChI IdentifierInChI=1S/C12H11NO2S/c1-6-7-5-13-8-3-2-4-9(10(7)8)16-11(6)12(14)15/h2-6,11,13H,1H3,(H,14,15)/t6-,11+/m0/s1
InChI KeyDKHFLDXCKWDVMF-UPONEAKYSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
1429.0 Log mg/kg [800:2500]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
CEDs000306Antibiotics?Antibiotics are synthetic or semi-synthetic compounds used to treat bacterial infections in humans and animals.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000685Ceramics?Ceramics can be a source of synthetic chemical contamination through various additives and processing agents used in their production.Building & ConstructionNot Available
Pathways
0 pathwaysPathway Source: PathBank

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
5-hydroxytryptamine receptor 2A structureClick to view 3D structure5-hydroxytryptamine receptor 2AP28223HumansPredicted (SEA)
Prediction Confidence Score
0.286
Applicability Domain
0.293 Low confidence
Statistical Significance
0.1108
Supporting Reference Compounds
955
E-value
862.336
5-hydroxytryptamine receptor 1A structureClick to view 3D structure5-hydroxytryptamine receptor 1AP08908HumansPredicted (SEA)
Prediction Confidence Score
0.285
Applicability Domain
0.293 Low confidence
Statistical Significance
0.1037
Supporting Reference Compounds
953
E-value
807.141
5-hydroxytryptamine receptor 2B structureClick to view 3D structure5-hydroxytryptamine receptor 2BP41595HumansPredicted (SEA)
Prediction Confidence Score
0.285
Applicability Domain
0.293 Low confidence
Statistical Significance
0.0793
Supporting Reference Compounds
686
E-value
617.734
D(3) dopamine receptor structureClick to view 3D structureD(3) dopamine receptorP35462HumansPredicted (SEA)
Prediction Confidence Score
0.282
Applicability Domain
0.288 Low confidence
Statistical Significance
0.1078
Supporting Reference Compounds
861
E-value
838.903
5-hydroxytryptamine receptor 6 structureClick to view 3D structure5-hydroxytryptamine receptor 6P50406HumansPredicted (SEA)
Prediction Confidence Score
0.282
Applicability Domain
0.288 Low confidence
Statistical Significance
0.0688
Supporting Reference Compounds
536
E-value
535.369
D(2) dopamine receptor structureClick to view 3D structureD(2) dopamine receptorP14416HumansPredicted (SEA)
Prediction Confidence Score
0.282
Applicability Domain
0.288 Low confidence
Statistical Significance
0.1341
Supporting Reference Compounds
1103
E-value
1044.19
5-hydroxytryptamine receptor 7 structureClick to view 3D structure5-hydroxytryptamine receptor 7P34969HumansPredicted (SEA)
Prediction Confidence Score
0.282
Applicability Domain
0.288 Low confidence
Statistical Significance
0.0742
Supporting Reference Compounds
565
E-value
577.486
D(4) dopamine receptor structureClick to view 3D structureD(4) dopamine receptorP21917HumansPredicted (SEA)
Prediction Confidence Score
0.282
Applicability Domain
0.288 Low confidence
Statistical Significance
0.0865
Supporting Reference Compounds
524
E-value
673.162
5-hydroxytryptamine receptor 5A structureClick to view 3D structure5-hydroxytryptamine receptor 5AP47898HumansPredicted (SEA)
Prediction Confidence Score
0.278
Applicability Domain
0.283 Low confidence
Statistical Significance
0.032
Supporting Reference Compounds
225
E-value
248.884
5-hydroxytryptamine receptor 2C structureClick to view 3D structure5-hydroxytryptamine receptor 2CP28335HumansPredicted (SEA)
Prediction Confidence Score
0.276
Applicability Domain
0.288 Low confidence
Statistical Significance
0.1263
Supporting Reference Compounds
823
E-value
983.002
5-hydroxytryptamine receptor 1D structureClick to view 3D structure5-hydroxytryptamine receptor 1DP28221HumansPredicted (SEA)
Prediction Confidence Score
0.275
Applicability Domain
0.283 Low confidence
Statistical Significance
0.0595
Supporting Reference Compounds
365
E-value
463.047
Click to view 3D structure5-hydroxytryptamine receptor 1AP19327Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.274
Applicability Domain
0.293 Low confidence
Statistical Significance
0.0976
Supporting Reference Compounds
541
E-value
759.653
5-hydroxytryptamine receptor 2A structureClick to view 3D structure5-hydroxytryptamine receptor 2AP14842Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.273
Applicability Domain
0.283 Low confidence
Statistical Significance
0.074
Supporting Reference Compounds
380
E-value
575.773
5-hydroxytryptamine receptor 1E structureClick to view 3D structure5-hydroxytryptamine receptor 1EP28566HumansPredicted (SEA)
Prediction Confidence Score
0.273
Applicability Domain
0.283 Low confidence
Statistical Significance
0.0223
Supporting Reference Compounds
139
E-value
173.604
D(1B) dopamine receptor structureClick to view 3D structureD(1B) dopamine receptorP21918HumansPredicted (SEA)
Prediction Confidence Score
0.273
Applicability Domain
0.283 Low confidence
Statistical Significance
0.0435
Supporting Reference Compounds
209
E-value
338.8
Beta-1 adrenergic receptor structureClick to view 3D structureBeta-1 adrenergic receptorP08588HumansPredicted (SEA)
Prediction Confidence Score
0.272
Applicability Domain
0.288 Low confidence
Statistical Significance
0.0262
Supporting Reference Compounds
180
E-value
204.043
Histamine H1 receptor structureClick to view 3D structureHistamine H1 receptorP35367HumansPredicted (SEA)
Prediction Confidence Score
0.269
Applicability Domain
0.279 Low confidence
Statistical Significance
0.1084
Supporting Reference Compounds
507
E-value
844.275
Click to view 3D structureD(2) dopamine receptorP61169RatPredicted (SEA)
Prediction Confidence Score
0.267
Applicability Domain
0.293 Low confidence
Statistical Significance
0.1112
Supporting Reference Compounds
528
E-value
865.372
D(1A) dopamine receptor structureClick to view 3D structureD(1A) dopamine receptorP21728HumansPredicted (SEA)
Prediction Confidence Score
0.266
Applicability Domain
0.288 Low confidence
Statistical Significance
0.088
Supporting Reference Compounds
425
E-value
685.385
Alpha-2A adrenergic receptor structureClick to view 3D structureAlpha-2A adrenergic receptorP08913HumansPredicted (SEA)
Prediction Confidence Score
0.261
Applicability Domain
0.288 Low confidence
Statistical Significance
0.1165
Supporting Reference Compounds
487
E-value
907.255
Click to view 3D structureD(1A) dopamine receptorP18901Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.26
Applicability Domain
0.293 Low confidence
Statistical Significance
0.0566
Supporting Reference Compounds
206
E-value
440.938
Alpha-2C adrenergic receptor structureClick to view 3D structureAlpha-2C adrenergic receptorP18825HumansPredicted (SEA)
Prediction Confidence Score
0.258
Applicability Domain
0.288 Low confidence
Statistical Significance
0.094
Supporting Reference Compounds
386
E-value
732.172
5-hydroxytryptamine receptor 1B structureClick to view 3D structure5-hydroxytryptamine receptor 1BP28222HumansPredicted (SEA)
Prediction Confidence Score
0.254
Applicability Domain
0.283 Low confidence
Statistical Significance
0.1154
Supporting Reference Compounds
337
E-value
898.536
Click to view 3D structure5-hydroxytryptamine receptor 2AP35363Mus musculusPredicted (SEA)
Prediction Confidence Score
0.253
Applicability Domain
0.288 Low confidence
Statistical Significance
0.0177
Supporting Reference Compounds
47
E-value
138.105
5-hydroxytryptamine receptor 2C structureClick to view 3D structure5-hydroxytryptamine receptor 2CP08909RatPredicted (SEA)
Prediction Confidence Score
0.25
Applicability Domain
0.279 Low confidence
Statistical Significance
0.0864
Supporting Reference Compounds
185
E-value
672.773
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available